HOPE Research Institute

Welcome


HOPE Research Institute is an independent, multi-specialty, research organization dedicated to conducting clinical research trials in partnership with Valley physicians and their patients.

With NIH certified investigators and ACRP certified study coordinators, HOPE Research Institute can conduct in-patient and out-patient clinical trials across the Phoenix area.



AAHRPP Accreditation

Member of Hunt
AAHRPP

HOPE Research Institute, LLC, conducts clinical research projects for the pharmaceutical industry in the Valley of the Sun, Phoenix, Arizona. Under the careful supervision of trained, experienced physicians, Valley residents can participate in studies of investigational products. HOPE's research facility is conveniently located in north Phoenix on Union Hills Drive near the intersection of freeways 51 and 101. Depending on a person's eligibility, subjects are placed into studies in a variety of therapeutic areas, which include: Neurology, Women's Health, Podiatry, Urology, Family Medicine, Allergy and Asthma, Orthopedics, or Ophthalmology. Study participation can be a positive experience for both the physician and the patient that may provide opportunities for learning, healthcare, and the betterment of our society.

Health and Clinical Research - Latest Headlines

Food and Drug Administration--Press Releases

  • FDA Updates Statement on the Investigation into the Salmonella Montevideo Outbreak - 04 Feb 2010The Food and Drug Administration, along with the Centers for Disease Control and Prevention and the U.S. Department of Agriculture?s Food Safety and Inspection Service, continues to work closely with the Rhode Island Department of Health and other states in the investigation of an outbreak of Salmonella Montevideo infections associated with certain Italian-style sausage products including salami/salame.
  • FDA Issues Guidance to Help Streamline Medical Device Clinical Trials - 05 Feb 2010The U.S. Food and Drug Administration today issued guidance on Bayesian statistical methods in the design and analysis of medical device clinical trials that could result in less costly and more efficient patient studies.
  • United States Seizes more than 1500 Cases of Food from Wisconsin Distribution Warehouse - 03 Feb 2010At the request of the U.S. Food and Drug Administration, U.S. Marshals on Tuesday seized a wide range of human and animal food products stored under insanitary conditions at Mid-States Closeouts, a distribution warehouse in Ellsworth, Wis. The products were seized under a warrant issued by the U.S. District Court for the Western District of Wisconsin.
  • FDA Approves Xiaflex for Debilitating Hand Condition - 03 Feb 2010The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person?s ability to straighten and properly use their fingers.
  • FDA Requests $4.03 Billion to Transform Food Safety System, Invest in Medical Product Safety, Regulatory Science - 01 Feb 2010The U.S. Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the President?s fiscal year 2011 budget ? a 23 percent increase over the agency?s current $3.28 billion budget. The FY 2011 request, which covers the period of Oct.1, 2010, through Sept. 30, 2011, includes increases of $146 million in budget authority and $601 million in industry user fees.

National Institutes of Health (NIH) News Releases

  • NCCAM's Advisory Council Welcomes Five New Members - 05 Feb 2010The National Center for Complementary and Alternative Medicine (NCCAM) welcomes five new members to the National Advisory Council for Complementary and Alternative Medicine (NACCAM). The council serves as the principal advisory body to NCCAM, the lead Federal agency for complementary and alternative medicine (CAM) research, and a component of the National Institutes of Health.
  • NIA Funds Roybal Centers for Translational Research in Aging - 04 Feb 2010The National Institute on Aging (NIA), part of the National Institutes of Health, today announced that it has renewed funding for nine Edward R. Roybal Centers for Research on Applied Gerontology and designated four new centers. The goal of the centers is to move promising social and behavioral research findings out of the laboratory and into programs and practices that will improve the lives of older people and help society adapt to an aging population. The centers focus on a range of projects, including maintaining mobility and physical function, enhancing driving performance, understanding financial and medical decision making, and sharpening cognitive function.
  • Four New Members Appointed to National Neurological Disorders and Stroke Advisory Council - 04 Feb 2010The National Institute of Neurological Disorders and Stroke (NINDS) announced that four new members have joined its National Advisory Neurological Disorders and Stroke Council. The council serves as the principal advisory body to NINDS regarding the Institute's research program planning and priorities.
  • Panel Calls for Reducing Colorectal Cancer Deaths by Striking Down Barriers to Screening - 04 Feb 2010Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical. Although the screening rates in the target population of adults over age 50, have increased from 20-30 percent in 1997 to nearly 55 percent in 2008 - the rates are still too low. An NIH state-of-the-science panel was convened this week to identify ways to further increase the use and quality of colorectal cancer screening in the United States.

World Health Organization News

  • WHO hails new Gates Foundation support for decade of vaccines - 29 Jan 201029 January 2010 -- WHO welcomes the Bill & Melinda Gates Foundation pledge of US$ 10 billion over the next ten years to accelerate global vaccine efforts.
  • Statement of the World Health Organization on allegations of conflict of interest and 'fake' pandemic - 22 Jan 201022 January 2010 -- Providing independent advice to Member States is a very important function of the World Health Organization (WHO). We take this work seriously and guard against the influence of any improper interests. The WHO influenza pandemic policies and response have not been improperly influenced by the pharmaceutical industry.
  • WHO Executive Board appoints Regional Directors - 18 Jan 201019 January 2010 -- The World Health Organization (WHO) Executive Board, currently holding its 126th session in Geneva, has appointed Mrs. Zsuzsanna Jakab as the new WHO Regional Director for Europe and re-appointed Dr Luis Gomes Sambo as the WHO Regional Director for Africa.
  • WHO spearheads health response to earthquake in Haiti - 12 Jan 201013 January 2010 -- The severe earthquake that has struck Haiti and the Dominican Republic has inflicted large-scale damage, including on hospitals and health facilities, and large numbers of casualties are feared. Immediate health priorities include search and rescue of survivors, treatment of injuries and preventing the infection of wounds.